HBM BioCapital (EUR) L.P. and HBM BioCapital (USD) L.P. are private equity funds with a total committed capital of EUR 115 million. The funds are managed by HBM Partners and are focused on healthcare / life science investments in Europe and the U.S. ...Show all
Phone: +41 43 888 7171
PO-Box 1145
Zug, CH-6301
Switzerland
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-06-20 | iTeos Therapeutics | Series B | $75M | 6 Dimensions Capital, Curative Ventures, Fund+, MPM Capital, Societe Federale de Participations et dInvestissement - Federale Participatie-en Investeringsmaatschappij, Technowal, and Vives |
| 2017-12-11 | Hookipa Biotech | Series C | $59.6M | BioMedPartners, Boehringer Ingelheim Venture Fund, Forbion Capital Partners, Gilead Sciences, Hillhouse Capital Management, Sirona Capital, Sofinnova Partners, and Takeda Ventures |
| 2017-10-24 | Y-mAbs | Private Equity | $50M | |
| 2017-03-27 | Vascular Dynamics | Series C | $10.4M | Invus Group, MedFocus Fund, and Rainbow Medical |
| 2015-11-17 | Gynesonics | Series E - II | $3M | Abingworth, Advanced Technology Ventures, Correlation Ventures, Endeavour Vision, HealthCrest, Hercules Capital, InterWest Partners, and NOVIT Ventures |
